強気
$26.08
シナリオ価格
$34.890
+0.031 (+0.09%)終値時点
RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals.
RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.
Benchmark
$36
2026-04-08
Benchmark
2026-04-08
目標株価
$36
Benchmark
$30
2025-03-21
Benchmark
2025-03-21
目標株価
$30
Benchmark
$37
2024-11-11
Benchmark
2024-11-11
目標株価
$37
B. Riley Securities
$37
2024-11-11
B. Riley Securities
2024-11-11
目標株価
$37
Benchmark
$33
2024-08-13
Benchmark
2024-08-13
目標株価
$33
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Zacks Adds Five Stocks to Strong Buy List

RCM Technologies Reports Significant Growth in Q2 Financial Results

RCM Technologies (RCMT.US) Officer Plans to Sell $4.78 Million in Common Stock via Form 144

RCM Technologies Q4 Earnings Exceed Expectations

RCM Technologies Reports Financial Results for FY 2026
RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).
RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.
1 analysts cover RCMT: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 32.00.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。